Corvus Pharmaceuticals Inc. (CRVS)
Market Closed
17 Jul, 20:00
$
14. 90
+0.63
+4.4149%
$
1.26B Market Cap
- P/E Ratio
- Div Yield
780,700 Volume
-0.55 Eps
$ 14.27
Previous Close 
Want to track CRVS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Corvus Pharmaceuticals Inc. (CRVS) Statistics
Valuation metrics
Market Cap 1.26B
Enterprise value 1.21B
Trailing P/E (ttm) -27.09
Forward P/E -
PEG ratio 0.11
Price/Sales (ttm) -
Price/Book (mrq) 5.57
Enterprise Value/Revenue -
Enterprise Value/EBITDA -28.71
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 773.45K
Average volume (90 days) 1.66M
Price summary
52-Week low 3.96
52-Week high 26.95
Beta -
50-Day moving average 13.27
200-Day moving average 15.22
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.17%
Return on equity -0.39%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.49
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.63
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 19.81%
Book value per share (mrq) 2.67
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
